Acute and subchronic effects of bilastine (20 and 40mg) and hydroxyzine (50mg) on actual driving performance in healthy volunteers

Journal of Psychopharmacology

Volumn 25, Issue 11, 2011, Pages 1517-1523

  Conen, Silke ^a   Theunissen, Eef L ^a   Van Oers, Anita C M ^a   Valiente, Román ^b   Ramaekers, Johannes G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b FAES FARMA SA Lejona   (Spain)

Author keywords

Antihistamine; bilastine; driving; hydroxyzine; sedation

Indexed keywords

BILASTINE; HYDROXYZINE; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; BACKACHE; CAR DRIVING; COMMON COLD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRIVING ABILITY; DROWSINESS; DRUG DOSE COMPARISON; DRUG ERUPTION; DRUG SAFETY; DRY EYE; ESOPHAGUS DISEASE; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN EXPERIMENT; INSOMNIA; MALE; MIGRAINE; NASAL PRURITUS; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SINUSITIS; TASK PERFORMANCE; VOLUNTEER; VOMITING; XEROSTOMIA;

ADULT; AUTOMOBILE DRIVING; BENZIMIDAZOLES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; HYDROXYZINE; MALE; MIDDLE AGED; PIPERIDINES; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

EID: 83455231391     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110382467     Document Type: Article

References (31)

1. Bachert C, Kuna P, Sanquer F, et al. Comparison of the efficacy and safety of bilastine 20mg vs desloratadine 5mg in seasonal allergic rhinitis patients. Allergy. 2009 ; 64: 158-165
2. Bartra J, Valero AL, del Cuvillo A, et al. Interactions of the H1 antihistamines. J Investig Allergol Clin Immunol. 2006 ; 16 (Suppl 1). 29-36
3. Borkenstein RF. Efficacy of law enforcement procedures concerning alcohol, drugs, and driving. Mod Probl Pharmacopsychiatry. 1976 ; 11: 1-10
4. Brookhuis KA, De Vries G, De Waard D. Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30mg dose, and triprolidine 10mg on car driving performance. Br J Clin Pharmacol. 1993 ; 36: 67-70 (Pubitemid 23205316)
5. Corcostegui R, Labeaga L, Innerarity A, Berisa A, Orjales A. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity. Drugs R D. 2005 ; 6: 371-384 (Pubitemid 41633390)
6. Corcostegui R, Labeaga L, Innerarity A, Berisa A, Orjales A. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. Drugs R D. 2006 ; 7: 219-231 (Pubitemid 43927202)
7. Gandon JM, Allain H. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. Br J Clin Pharmacol. 2002 ; 54: 51-58 (Pubitemid 36124754)
8. Garcia-Gea C, Martinez-Colomer J, Antonijoan RM, Valiente R, Barbanoj MJ. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments. J Clin Psychopharmacol. 2008 ; 28: 675-685
9. Gillin JC, Sutton L, Ruiz C, et al. Dose dependent inhibition of REM sleep in normal volunteers by biperiden, a muscarinic antagonist. Biol Psychiatry. 1991 ; 30: 151-156
10. Horak F, Zieglmayer P, Zieglmayer R, Lemell P. The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. Inflamm Res. 2009 ; 59: 391-398
11. Levander S, Stahle-Backdahl M, Hagermark O. Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine. Eur J Clin Pharmacol. 1991 ; 41: 435-439
12. Lieberman JA. Managing anticholinergic side effects. Prim Care Companion J Clin Psychiatry. 2004 ; 6 (Suppl 2). 20-23
13. Louwerens JW, Gloerich ABM, de Vries G, Brookhuis KA and O'Hanlon JF (1987) The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: Noordzij PC and Roszbach R (eds), Proceedings of the International Congress on Alcohol, Drugs and Traffic Safety, T86. Amsterdam: Exerpta Medica.
14. Mulder-Hajonides van der Meulen WREH (1981) Measurments of subjective sleep quality. In: Proceedings of the Proceedings of International European Sleep Congress. Amsterdam: Elsevier.
15. O'Hanlon JF. Are actual driving tests necessary for evaluating drug safety?. Int Clin Psychopharmacol. 1988 ; 3 (Suppl 1). 81-85
16. O'Hanlon JF, Haak TW, Blaauw GJ, Riemersma JB. Diazepam impairs lateral position control in highway driving. Science. 1982 ; 217: 79-81 (Pubitemid 12019254)
17. O'Hanlon JF, Ramaekers JG. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94. Allergy. 1995 ; 50: 234-242
18. Penttila J, Scheinin H, Syvalahti E. Measurement of anticholinergic effects of psychotropic drugs in humans. Pharmacopsychiatry. 2005 ; 38: 187-193 (Pubitemid 41414863)
19. Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry. 2003 ; 64: 20-29 (Pubitemid 36182225)
20. Ramaekers JG, O'Hanlon JF. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol. 1994 ; 47: 261-266 (Pubitemid 24330668)
21. Ramaekers JG, Uiterwijk MM, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992 ; 42: 363-369
22. Richardson GS, Roehrs TA, Rosenthal L, Koshorek G, Roth T. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol. 2002 ; 22: 511-515
23. Theunissen EL, Jonkman LM, Kuypers KP, Ramaekers JG. A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance. J Psychopharmacol. 2006a ; 20: 496-505 (Pubitemid 43875179)
24. Theunissen EL, van Kroonenburgh MJ, van Deursen JA, Blom-Coenjaerts C, Ramaekers JG. Stimulating effects of fexofenadine: testing the dopamine transporter hypothesis. Psychopharmacology. 2006b ; 187: 95-102 (Pubitemid 43876921)
25. Theunissen EL, Vermeeren A, Ramaekers JG. Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. Br J Clin Pharmacol. 2006c ; 61: 79-86 (Pubitemid 43381240)
26. Theunissen EL, Vermeeren A, van Oers AC, van Maris I, Ramaekers JG. A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. Clin Exp Allergy. 2004 ; 34: 250-258 (Pubitemid 38315262)
27. Vermeeren A, O'Hanlon JF. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol. 1998 ; 101: 306-311 (Pubitemid 28146347)
28. Vermeeren A, Ramaekers JG, O'Hanlon JF. Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. J Psychopharmacol. 2002 ; 16: 57-64 (Pubitemid 34273074)
29. Verster JC, Volkerts ER. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol. 2004 ; 92: 294-303
30. Verster JC, Volkerts ER, van Oosterwijck AW, et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol. 2003 ; 111: 623-627 (Pubitemid 36337888)
31. Zuberbier T, Oanta A, Bogacka E, et al. Comparison of the efficacy and safety of bilastine 20mg vs levocetirizine 5mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study. Allergy. 2009 ; 65: 516-528